Big data modeling to predict platelet usage and minimize wastage in a tertiary care system

Significance In modern hospital systems where complicated, severely ill patient populations are the norm, there is currently no reliable way to forecast the use of perishable medical resources to enable a smart and economic way to deliver optimal patient care. We here demonstrate a statistical model using hospital patient data to quantitatively forecast, days in advance, the need for platelet transfusions. This approach can be leveraged to significantly decrease platelet wastage, and, if adopted nationwide, would save approximately 80 million dollars per year. We believe our approach can be generalized to all other aspects of patient care involving timely delivery of perishable medical resources. Maintaining a robust blood product supply is an essential requirement to guarantee optimal patient care in modern health care systems. However, daily blood product use is difficult to anticipate. Platelet products are the most variable in daily usage, have short shelf lives, and are also the most expensive to produce, test, and store. Due to the combination of absolute need, uncertain daily demand, and short shelf life, platelet products are frequently wasted due to expiration. Our aim is to build and validate a statistical model to forecast future platelet demand and thereby reduce wastage. We have investigated platelet usage patterns at our institution, and specifically interrogated the relationship between platelet usage and aggregated hospital-wide patient data over a recent consecutive 29-mo period. Using a convex statistical formulation, we have found that platelet usage is highly dependent on weekday/weekend pattern, number of patients with various abnormal complete blood count measurements, and location-specific hospital census data. We incorporated these relationships in a mathematical model to guide collection and ordering strategy. This model minimizes waste due to expiration while avoiding shortages; the number of remaining platelet units at the end of any day stays above 10 in our model during the same period. Compared with historical expiration rates during the same period, our model reduces the expiration rate from 10.5 to 3.2%. Extrapolating our results to the ∼2 million units of platelets transfused annually within the United States, if implemented successfully, our model can potentially save ∼80 million dollars in health care costs.

[1]  P. Marks,et al.  Maintaining a Safe Blood Supply in an Era of Emerging Pathogens. , 2016, The Journal of infectious diseases.

[2]  J. Hess,et al.  Will pathogen reduction of blood components harm more people than it helps in developed countries? , 2016, Transfusion.

[3]  M. Nybo,et al.  Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia , 2016, Platelets.

[4]  P. Morel,et al.  Improving platelet transfusion safety: biomedical and technical considerations. , 2016, Blood transfusion = Trasfusione del sangue.

[5]  M. Zembala,et al.  Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery , 2015, Clinical cardiology.

[6]  L. Estcourt Why has demand for platelet components increased? A review , 2014, Transfusion medicine.

[7]  P. Meer Platelet concentrates, from whole blood or collected by apheresis? , 2013 .

[8]  N. Tynngård Preparation, storage and quality control of platelet concentrates. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[9]  B. Solheim Pathogen reduction of blood components. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[10]  D. Jaspan Erythropoietic therapy: cost efficiency and reimbursement. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[11]  Scott Murphy,et al.  A critical comparison of platelet preparation methods , 2006, Current opinion in hematology.

[12]  J. Epstein,et al.  FDA approach to evaluation of pathogen reduction technology , 2003, Transfusion.

[13]  M. Postma,et al.  Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States , 2003, Clinical Therapeutics.

[14]  R. Cardigan,et al.  The quality of platelets after storage for 7 days , 2003, Transfusion medicine.

[15]  G. Grunwald,et al.  Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. , 2003, Archives of pathology & laboratory medicine.

[16]  R. Dodd Bacterial contamination and transfusion safety: experience in the United States. , 2003, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[17]  D. Theriaque,et al.  Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions , 2001, Transfusion.

[18]  J. Findlay,et al.  Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. , 2000, Journal of clinical anesthesia.

[19]  J. Weissfeld,et al.  The cost‐effectiveness of reducing donor exposures with single‐donor versus pooled random‐donor platelets , 1999, Transfusion.

[20]  D P Connelly,et al.  Automatic prediction of platelet utilization by time series analysis in a large tertiary care hospital. , 1985, American journal of clinical pathology.

[21]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[22]  P. F. van der Meer Platelet concentrates, from whole blood or collected by apheresis? , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[23]  R. Tibshirani Regression Shrinkage and Selection via the Lasso , 1996 .